TrialPharmacology research & perspectives2020

Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next-generation HIV-1 maturation inhibitor.

Samit R Joshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.